The charts on this page feature a breakdown of the total annual pay for the top executives at BIODELIVERY SCIENCES INTERNATIONAL INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. BIODELIVERY SCIENCES INTERNATIONAL INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. BIODELIVERY SCIENCES INTERNATIONAL INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Mark A. Sirgo Pharm.D.
Vice Chairman and Director
Total Cash $68,385 Equity $792,000 Other $978,249 Total Compensation $1,838,634
Niraj Vasisht Ph.D.
Former Senior VP and Chief Technology Officer
Total Cash $58,078 Equity $525,000 Other $358,823 Total Compensation $941,901
Ernest R. De Paolantonio CPA MBA
Former Chief Financial Officer and Treasurer
Total Cash $532,800 Equity $294,000 Other $32,790 Total Compensation $859,590
James Vollins
General Counsel, Chief Compliance Officer and Corporate Secretary
Total Cash $76,731 Equity $210,269 Other $351 Total Compensation $287,351
Herm Cukier
Chief Executive Officer and Director
Total Cash $640,589 Equity $1,814,000 Other $14,459 Total Compensation $2,469,048
Thomas Smith M.D.
Chief Medical Officer
Total Cash $214,421 Equity $165,944 Other $3,441 Total Compensation $383,806
Scott M. Plesha
President and Chief Commercial Officer
Total Cash $551,755 Equity $332,813 Other $34,423 Total Compensation $918,991
For its 2018 fiscal year, BIODELIVERY SCIENCES INTERNATIONAL INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Herm Cukier CEO Pay $2,679,509 Median Employee Pay $125,563 CEO Pay Ratio 21:1
For its 2018 fiscal year, BIODELIVERY SCIENCES INTERNATIONAL INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Barry I. Feinberg Total Cash $98,382
Kevin Kotler Total Cash $349,147
Peter S. Greenleaf Total Cash $418,491
Samuel P. Sears, Jr. Total Cash $110,882
Timothy C. Tyson Total Cash $85,257
Todd C. Davis Total Cash $353,817
William M. Watson Total Cash $437,584

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.